Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Weights and Measures × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 4 Neoplasms 3 Anxiety Disorders 3 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Weight Gain 1 Vomiting 1 Triple Negative Breast Neoplasms 1 Treatment Adherence and Compliance 1 Sclerosteosis 1 Recurrence 1 Periodontitis 1 Periodontal Diseases 1 Patient Compliance 1 Osteoporosis, Postmenopausal 1 Obesity 1 Nausea 1 Motor Activity 1 Lymphedema 1 Liver Cirrhosis 1 Leukemia, Promyelocytic, Acute 1 Inflammation 1 Gastrointestinal Neoplasms 1 Feeding Behavior 1 Dendritic Cell Sarcoma, Interdigitating 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Arsenic Trioxide 23 Tretinoin 21 Cytarabine 18 Idarubicin 12 Cyclophosphamide 12 Filgrastim 10 Methotrexate 9 Busulfan 9 Etoposide 8 fludarabine phosphate 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Gemtuzumab 6 Daunorubicin 6 Mitoxantrone 5 Mercaptopurine 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Tacrolimus 4 Antilymphocyte Serum 4 Sorafenib 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2 lintuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01910623 2014-10-02

QOL-APL0512

Gruppo Italiano Malattie EMatologiche dell'Adulto

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡